PTCE and NCODA Partner for Oncology-Focused Continuing Education


PTCE, the industry-leading continuing pharmacy education provider, becomes sole provider for association’s 3 major meetings through 2021.

Pharmacy Times Continuing Education (PTCE) proudly has announced it is now the exclusive continuing education (CE) provider for the National Community Oncology Dispensing Association, Inc. (NCODA) 2020-2021 meetings.

NCODA provides its medically integrated dispensing pharmacy team members with the opportunity to attend their 2 national marquee meeting events, the NCODA Spring Forum and the NCODA Fall Summit. These meetings allow the NCODA membership to share best practices and discuss the present-day oncology landscape. Through this partnership with PTCE, NCODA’s members will gain access to targeted CE programming that supports positive clinical outcomes, interventions, and patient care by exploring treatment and management considerations for patients receiving oncolytics.

“We’re very excited to join forces with NCODA to provide their audiences with high-quality content as their national meeting CE provider,” said Jim Palatine, RPh, MBA, president of PTCE, in a prepared statement. “NCODA’s annual meetings have been a driver of change to improve and advance the medically integrated dispensing pharmacy services for oncology practices. We look forward to using our platforms, as well as expert speakers and resources, to help achieve its goals to enhance education for health care professionals who provide care to patients with cancer.”

PTCE will have exclusivity to provide 6 CE-accredited sessions to NCODA physicians, pharmacists, nurses, and pharmacy technician members at each of the following NCODA meetings:

  • 2020 NCODA National Fall Summit Virtual E-Meeting, Oct. 22-23, 2020.
  • 2021 NCODA National Spring Forum, location, and date TBD.
  • 2021 NCODA National Fall Summit, location, and date TBD.

“We are excited about this partnership,” said Michael Reff, executive director, and founder of NCODA, in a prepared statement. “We know that through working with PTCE, our membership will have many of their needs met from an educational perspective. We look forward to delivering on our mission of being patient-centric and collaborative with the help of our new partner, PTCE.”

PTCE is a brand of MJH Life Sciences™, the largest privately held, independent, full-service medical media company in North America, and parent company to Pharmacy TimesTM.

For more information on joining NCODA and attending NCODA’s 2020 National Fall Summit virtual e-meeting, visit the organization’s website.


PTCE and NCODA to Partner in Bringing Oncology-Focused Continuing Education to the NCODA Membership [news release]. Cranbury, NJ; August 26, 2020: PTCE. Accessed August 26, 2020.

Recent Videos
Naloxone concept represented by wooden letter tiles.
Hand holding a Narcan Evzio Naloxone nasal spray opioid drug overdose prevention medication
Catalyst Trial, Diabetes, Hypertension | Image Credit: grinny -
Image Credit: © Anastasiia -
LGBTQIA+ pride -- Image credit: lazyllama |
Image Credit: © Анастасія Стягайло -
breast cancer treatment/Image Credit: © Siam -
Image Credit: © Dragana Gordic -
small cell lung cancer treatment/Image Credit: © CraftyImago -